CA Stock MarketDetailed Quotes

BBM Blueberries Medical Corp

Watchlist
  • 0.015
  • +0.005+50.00%
15min DelayTrading Jan 23 13:27 ET
5.99MMarket Cap-2.50P/E (TTM)

Blueberries Medical Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-19.04%-204.31K
69.69%-149.73K
53.56%-212.89K
9.26%-1.33M
6.69%-208.6K
24.23%-171.64K
8.18%-493.92K
4.62%-458.39K
12.60%-1.47M
56.09%-223.56K
Net income from continuing operations
45.58%-175.97K
33.43%-328.38K
41.44%-257.96K
-11.41%-1.64M
-5,825.86%-378.25K
-5.52%-323.37K
3.60%-493.27K
32.88%-440.48K
71.48%-1.47M
100.17%6.61K
Operating gains losses
-26.69%-35.69K
----
----
86.19%-75.15K
76.37%-93.54K
78.66%-28.17K
----
----
-44.65%-544.04K
-16.80%-395.87K
Depreciation and amortization
-73.36%26.56K
2,305.41%24.46K
91.75%26.95K
-49.47%149.74K
481.81%34.97K
-27.19%99.7K
-98.79%1.02K
-83.40%14.06K
-64.23%296.33K
-104.64%-9.16K
Asset impairment expenditure
----
----
----
--180.64K
----
----
----
----
--0
----
Remuneration paid in stock
----
----
----
160.60%20.78K
----
----
----
----
-176.20%-34.3K
----
Remuneration paid in stock
-15.21%11.05K
-23.24%13.4K
-24.35%15.65K
-16.45%111.45K
99.42%60.26K
-58.65%13.03K
-35.77%17.46K
-53.47%20.69K
139.28%133.4K
-40.03%30.22K
Other non cashItems
-101.42%-250
-117.31%-19.73K
-83.05%20.21K
14.37%263.84K
130.21%13.08K
-84.72%17.56K
47.77%113.93K
45.43%119.27K
-20.98%230.7K
-177.08%-43.3K
Change In working capital
-160.49%-30.01K
134.62%62.18K
89.67%-17.75K
-321.08%-348.47K
-120.94%-46.55K
169.50%49.61K
-4.43%-179.61K
-178.99%-171.92K
77.72%-82.76K
558.09%222.24K
-Change in receivables
-141.72%-71.65K
183.35%128.64K
56.23%-26.1K
----
----
67.97%-29.64K
-97.41%-154.34K
-57,243.27%-59.64K
-127.75%-19.74K
326.98%151.09K
-Change in inventory
96.69%-528
119.07%17.22K
89.16%-5.01K
----
----
10.13%-15.95K
---90.3K
---46.19K
---12.31K
-93.34%5.43K
-Change in prepaid assets
-32.49%35.41K
217.82%22.59K
-25.50%-60.94K
----
----
158.34%52.45K
-72.09%-19.17K
-113.16%-48.56K
-63.36%-21.53K
-153.35%-7.91K
-Change in payables and accrued expense
-95.44%1.92K
-207.50%-105.92K
763.12%80.97K
----
----
515.46%42.03K
213.91%98.53K
56.37%-12.21K
93.05%-30.17K
141.45%77.49K
-Change in other working capital
572.12%4.85K
97.56%-350
-25.32%-6.67K
----
----
-93.87%721
-473.30%-14.33K
50.47%-5.32K
-78.95%1K
-158.05%-3.86K
Cash from discontinued investing activities
Operating cash flow
-19.04%-204.31K
69.69%-149.73K
53.56%-212.89K
9.26%-1.33M
6.70%-208.6K
24.23%-171.64K
8.18%-493.92K
4.62%-458.39K
12.60%-1.47M
56.09%-223.56K
Investing cash flow
Cash flow from continuing investing activities
0
-94.34%12.76K
0
275.63%382.92K
1,662.40%140.62K
19.53K
103.36%225.61K
-2.83K
309.01%101.94K
-273.29%-9K
Net PPE purchase and sale
--0
-94.34%12.76K
--0
275.63%382.92K
1,662.40%140.62K
--19.53K
103.36%225.61K
---2.83K
1,168.54%101.94K
-1,955.67%-9K
Cash from discontinued investing activities
Investing cash flow
--0
-94.34%12.76K
--0
275.63%382.92K
1,662.40%140.62K
--19.53K
103.36%225.61K
---2.83K
309.01%101.94K
-273.29%-9K
Financing cash flow
Cash flow from continuing financing activities
98.95%-138
89.68%-1.24K
97.29%-498
-59.96%539.1K
-58.92%582.57K
69.30%-13.08K
-429.01%-12.01K
44.26%-18.38K
-51.32%1.35M
5,351.62%1.42M
Net issuance payments of debt
98.95%-138
89.68%-1.24K
97.29%-498
-1,093.38%-1.44M
-2,556.75%-1.4M
66.33%-13.08K
-429.01%-12.01K
44.26%-18.38K
12.56%-120.83K
-94.92%-52.64K
Net common stock issuance
----
----
----
35.03%1.98M
----
----
----
----
-48.30%1.47M
----
Cash from discontinued financing activities
Financing cash flow
98.95%-138
89.68%-1.24K
97.29%-498
-59.96%539.1K
-58.92%582.57K
69.30%-13.08K
-429.01%-12.01K
44.26%-18.38K
-51.32%1.35M
5,351.62%1.42M
Net cash flow
Beginning cash position
-27.83%452.46K
-30.76%628.16K
-42.09%818.16K
5.18%1.41M
400.21%594.26K
34.21%626.95K
5.90%907.27K
5.18%1.41M
338.21%1.34M
-93.48%118.8K
Current changes in cash
-23.77%-204.45K
50.70%-138.2K
55.51%-213.39K
-1,916.64%-410.53K
-56.60%514.59K
38.62%-165.19K
33.78%-280.33K
6.61%-479.6K
-101.96%-20.36K
320.16%1.19M
Effect of exchange rate changes
-97.51%3.29K
---37.49K
190.32%23.39K
-304.58%-184.08K
-368.35%-290.69K
267.32%132.51K
--0
-195.53%-25.89K
--89.98K
81.16%108.33K
End cash Position
-57.71%251.31K
-27.83%452.46K
-30.76%628.16K
-42.09%818.16K
-42.09%818.16K
400.21%594.26K
34.21%626.95K
5.90%907.27K
5.18%1.41M
5.18%1.41M
Free cash from
-18.46%-204.31K
70.76%-149.73K
53.84%-212.89K
7.74%-1.35M
6.48%-209.09K
23.86%-172.48K
4.80%-512.11K
4.03%-461.22K
15.07%-1.47M
56.30%-223.56K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -19.04%-204.31K69.69%-149.73K53.56%-212.89K9.26%-1.33M6.69%-208.6K24.23%-171.64K8.18%-493.92K4.62%-458.39K12.60%-1.47M56.09%-223.56K
Net income from continuing operations 45.58%-175.97K33.43%-328.38K41.44%-257.96K-11.41%-1.64M-5,825.86%-378.25K-5.52%-323.37K3.60%-493.27K32.88%-440.48K71.48%-1.47M100.17%6.61K
Operating gains losses -26.69%-35.69K--------86.19%-75.15K76.37%-93.54K78.66%-28.17K---------44.65%-544.04K-16.80%-395.87K
Depreciation and amortization -73.36%26.56K2,305.41%24.46K91.75%26.95K-49.47%149.74K481.81%34.97K-27.19%99.7K-98.79%1.02K-83.40%14.06K-64.23%296.33K-104.64%-9.16K
Asset impairment expenditure --------------180.64K------------------0----
Remuneration paid in stock ------------160.60%20.78K-----------------176.20%-34.3K----
Remuneration paid in stock -15.21%11.05K-23.24%13.4K-24.35%15.65K-16.45%111.45K99.42%60.26K-58.65%13.03K-35.77%17.46K-53.47%20.69K139.28%133.4K-40.03%30.22K
Other non cashItems -101.42%-250-117.31%-19.73K-83.05%20.21K14.37%263.84K130.21%13.08K-84.72%17.56K47.77%113.93K45.43%119.27K-20.98%230.7K-177.08%-43.3K
Change In working capital -160.49%-30.01K134.62%62.18K89.67%-17.75K-321.08%-348.47K-120.94%-46.55K169.50%49.61K-4.43%-179.61K-178.99%-171.92K77.72%-82.76K558.09%222.24K
-Change in receivables -141.72%-71.65K183.35%128.64K56.23%-26.1K--------67.97%-29.64K-97.41%-154.34K-57,243.27%-59.64K-127.75%-19.74K326.98%151.09K
-Change in inventory 96.69%-528119.07%17.22K89.16%-5.01K--------10.13%-15.95K---90.3K---46.19K---12.31K-93.34%5.43K
-Change in prepaid assets -32.49%35.41K217.82%22.59K-25.50%-60.94K--------158.34%52.45K-72.09%-19.17K-113.16%-48.56K-63.36%-21.53K-153.35%-7.91K
-Change in payables and accrued expense -95.44%1.92K-207.50%-105.92K763.12%80.97K--------515.46%42.03K213.91%98.53K56.37%-12.21K93.05%-30.17K141.45%77.49K
-Change in other working capital 572.12%4.85K97.56%-350-25.32%-6.67K---------93.87%721-473.30%-14.33K50.47%-5.32K-78.95%1K-158.05%-3.86K
Cash from discontinued investing activities
Operating cash flow -19.04%-204.31K69.69%-149.73K53.56%-212.89K9.26%-1.33M6.70%-208.6K24.23%-171.64K8.18%-493.92K4.62%-458.39K12.60%-1.47M56.09%-223.56K
Investing cash flow
Cash flow from continuing investing activities 0-94.34%12.76K0275.63%382.92K1,662.40%140.62K19.53K103.36%225.61K-2.83K309.01%101.94K-273.29%-9K
Net PPE purchase and sale --0-94.34%12.76K--0275.63%382.92K1,662.40%140.62K--19.53K103.36%225.61K---2.83K1,168.54%101.94K-1,955.67%-9K
Cash from discontinued investing activities
Investing cash flow --0-94.34%12.76K--0275.63%382.92K1,662.40%140.62K--19.53K103.36%225.61K---2.83K309.01%101.94K-273.29%-9K
Financing cash flow
Cash flow from continuing financing activities 98.95%-13889.68%-1.24K97.29%-498-59.96%539.1K-58.92%582.57K69.30%-13.08K-429.01%-12.01K44.26%-18.38K-51.32%1.35M5,351.62%1.42M
Net issuance payments of debt 98.95%-13889.68%-1.24K97.29%-498-1,093.38%-1.44M-2,556.75%-1.4M66.33%-13.08K-429.01%-12.01K44.26%-18.38K12.56%-120.83K-94.92%-52.64K
Net common stock issuance ------------35.03%1.98M-----------------48.30%1.47M----
Cash from discontinued financing activities
Financing cash flow 98.95%-13889.68%-1.24K97.29%-498-59.96%539.1K-58.92%582.57K69.30%-13.08K-429.01%-12.01K44.26%-18.38K-51.32%1.35M5,351.62%1.42M
Net cash flow
Beginning cash position -27.83%452.46K-30.76%628.16K-42.09%818.16K5.18%1.41M400.21%594.26K34.21%626.95K5.90%907.27K5.18%1.41M338.21%1.34M-93.48%118.8K
Current changes in cash -23.77%-204.45K50.70%-138.2K55.51%-213.39K-1,916.64%-410.53K-56.60%514.59K38.62%-165.19K33.78%-280.33K6.61%-479.6K-101.96%-20.36K320.16%1.19M
Effect of exchange rate changes -97.51%3.29K---37.49K190.32%23.39K-304.58%-184.08K-368.35%-290.69K267.32%132.51K--0-195.53%-25.89K--89.98K81.16%108.33K
End cash Position -57.71%251.31K-27.83%452.46K-30.76%628.16K-42.09%818.16K-42.09%818.16K400.21%594.26K34.21%626.95K5.90%907.27K5.18%1.41M5.18%1.41M
Free cash from -18.46%-204.31K70.76%-149.73K53.84%-212.89K7.74%-1.35M6.48%-209.09K23.86%-172.48K4.80%-512.11K4.03%-461.22K15.07%-1.47M56.30%-223.56K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.